An open-label, multiple-dose study of the pharmacokinetics of tigecycline in human bone,

Trial Profile

An open-label, multiple-dose study of the pharmacokinetics of tigecycline in human bone,

Completed
Phase of Trial: Phase I

Latest Information Update: 08 Oct 2013

At a glance

  • Drugs Tigecycline (Primary)
  • Indications Bacterial infections; Community-acquired pneumonia; Diabetic foot ulcer; Intra-abdominal infections; Methicillin-resistant Staphylococcus aureus infections; Nosocomial pneumonia; Skin and soft tissue infections
  • Focus Pharmacokinetics
  • Sponsors Wyeth
  • Most Recent Events

    • 09 Jul 2009 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
    • 21 Dec 2007 The expected completion date for this trial is now 1 Oct 2008.
    • 11 May 2007 Status changed from initiated to recruiting.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top